BAP1 and clear cell renal carcinoma: In some solid tumors, such as advanced clear cell renal cell carcinoma, BAP1 alterations have been reported as a significant predictor of the immune microenvironment and have been associated with a longer progression-free survival (PFS) in patients when treated with ICI (27).